376 related articles for article (PubMed ID: 16146201)
1. Successful treatment of renal cell carcinoma with mediastinal lymph node metastasis by interleukin-2: a case report.
Tokunaga M; Masuda A; Mukai M; Nakamura H; Iwaki K; Terachi T
Tokai J Exp Clin Med; 2005 Jul; 30(2):111-5. PubMed ID: 16146201
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment for patients with solitary metastasis in the mediastinal lymph node from renal cell carcinoma.
Kanzaki R; Higashiyama M; Okami J; Kodama K
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):485-7. PubMed ID: 19126555
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
4. [Renal cell carcinoma recurrence in the mediastinum lymph node 19 years after nephrectomy: a case report].
Niikura S; Hirata A; Kunimi K; Yokoyama O; Koshida K; Uchibayashi T; Namiki M; Nishino A; Kameda K
Hinyokika Kiyo; 1999 Jun; 45(6):419-21. PubMed ID: 10442285
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Hoshi K; Kanbara T; Kawasaki Y; Ikeda Y; Namima T; Ohnuma T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1315-7. PubMed ID: 17687222
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
7. [A case of renal cell carcinoma with lymph node metastasis keeping remission for five years by adjuvant immunotherapy with ubenimex].
Sugano O; Muto A; Kato M; Ono K
Gan To Kagaku Ryoho; 2003 Oct; 30(10):1519-22. PubMed ID: 14584289
[TBL] [Abstract][Full Text] [Related]
8. "Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen.
Giacosa R; Santi R; Vaglio A; Pavone L; Ferrozzi F; Passalacqua R; Buzio C
Acta Biomed; 2004 Aug; 75(2):126-30. PubMed ID: 15481703
[TBL] [Abstract][Full Text] [Related]
9. Extension of survival by resection of asynchronous renal cell carcinoma metastases to mediastinal lymph nodes.
Whitson BA; Groth SS; Andrade RS; Garrett L; Dudek AZ; Jessurun J; Maddaus MA
J Thorac Cardiovasc Surg; 2008 May; 135(5):1022-8. PubMed ID: 18455579
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma with retroperitoneal lymph nodes. Impact on survival and benefits of immunotherapy.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz B; Belldegrun AS; Figlin RA
Cancer; 2003 Jun; 97(12):2995-3002. PubMed ID: 12784334
[TBL] [Abstract][Full Text] [Related]
11. [Recent management of renal cell carcinoma].
Nishio Y; Yoshida O
Gan To Kagaku Ryoho; 1988 Feb; 15(2):219-23. PubMed ID: 3257677
[TBL] [Abstract][Full Text] [Related]
12. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
Sakata Y; Ogura Y; Wakita T; Hayashi N; Sugimura Y
Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.
Verra N; de Jong D; Bex A; Batchelor D; Dellemijn T; Sein J; Nooijen W; Meinhardt W; Horenblas S; de Gast G; Vyth-Dreese F
Eur Urol; 2005 Sep; 48(3):527-33. PubMed ID: 16115526
[TBL] [Abstract][Full Text] [Related]
14. [IL-2 bronchoscopic istillation and immune cell activation: preliminary results of the BRIIL-2 study for treatment of pulmonary metastasis from renal cancer and melanoma].
Filippetti M; Torsello A; Cordiali Fei P; Bordignon V; Trento E; Tonachella R; Piperno G; Prignano G
Clin Ter; 2009; 160(2):139-43. PubMed ID: 19452104
[TBL] [Abstract][Full Text] [Related]
15. [A case of interferon-alpha-resistant renal cell carcinoma responding to interleukin-2 therapy].
Kobori G; Yamada H; Higashi Y
Hinyokika Kiyo; 2008 Oct; 54(10):657-9. PubMed ID: 19048930
[TBL] [Abstract][Full Text] [Related]
16. [Late recurrence of renal cell carcinoma: report of three cases].
Ishibashi Y; Fukuoka H; Tsuchiya F; Shiba T; Sakanishi S
Hinyokika Kiyo; 1994 Mar; 40(3):229-32. PubMed ID: 8178740
[TBL] [Abstract][Full Text] [Related]
17. Multifocal metastases of recurrent renal cell carcinoma successfully treated with a combination of low dose interleukin-2, alpha-interferon and radiotherapy.
Sawada N; Fukasawa M; Araki I; Kira S; Manabu K; Takeda M
Int J Urol; 2005 Nov; 12(11):994-5. PubMed ID: 16351657
[TBL] [Abstract][Full Text] [Related]
18. [Renal cell carcinoma].
Shimazui T; Kawai K; Akaza H
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2073-5. PubMed ID: 15570943
[TBL] [Abstract][Full Text] [Related]
19. Bladder metastasis of renal cell carcinoma; a case study.
Kagota M; Irie K; Hosaka K; Takezaki T
Hinyokika Kiyo; 2007 Aug; 53(8):571-4. PubMed ID: 17874550
[TBL] [Abstract][Full Text] [Related]
20. Regression of pulmonary and multiple skeletal metastases from renal cell carcinoma by nephrectomy and alpha-interferon therapy: a case report.
Ibayashi K; Ando M; Gotoh E
Jpn J Clin Oncol; 1993 Dec; 23(6):378-83. PubMed ID: 8283792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
